Domain Associates
  • About
  • Team
  • Portfolio
  • News
  • Contact

Portfolio

Less Detail More Detail
  • 3F Therapeutics, Inc.

    3F Therapeutics, Inc.

    Devices to treat heart valve disorders
    Acquired by ATS Medical, Inc.; Acquired by Medtronic
  • Achaogen, Inc.

    Achaogen, Inc.

    Pursuing unique strategies to prevent drug resistance
    http://www.achaogen.com
  • Achillion Pharmaceuticals, Inc.

    Achillion Pharmaceuticals, Inc.

    Dedicated to bringing important new treatments to patients with infectious disease
    http://www.achillion.com
    Acquired by Alexion Pharmaceuticals, Inc.
  • Acureon Pharmaceuticals, Inc.

    Acureon Pharmaceuticals, Inc.

    Acquire and market drugs focused on infectious diseases, transplant and ICU
    http://www.acureonpharma.com
  • Adastra Pharmaceuticals, Inc.

    Adastra Pharmaceuticals, Inc.

    Development of proprietary drugs for the treatment of cancer and inflammation-related disorders
    http://www.adastrarx.com
  • Adynxx, Inc.

    Adynxx, Inc.

    Focused on the treatment of acute and chronic pain
    http://www.adynxx.com
    Merged with Alliqua BioMedical; renamed Adynxx, Inc.
  • Aesthetic Sciences Corporation

    Aesthetic Sciences Corporation

    Focused on aesthetic medicine and incontinence
  • Afferent Pharmaceuticals, Inc.

    Afferent Pharmaceuticals, Inc.

    Focused on developing first-in-class medicines to treat pain
    http://www.afferentpharma.com
    Acquired by Merck
  • Aldeyra Therapeutics, Inc.

    Aldeyra Therapeutics, Inc.

    Developing next-generation medicines to improve the lives of patients with immune-mediated diseases
    http://www.aldeyra.com
  • Align Technology, Inc.

    Align Technology, Inc.

    Invisalign® invisible braces
    http://www.aligntech.com
  • Alimera Sciences, Inc.

    Alimera Sciences, Inc.

    Development and marketing of in-licensed ophthalmology products
    http://www.alimerasciences.com
  • Altair Therapeutics, Inc.

    Altair Therapeutics, Inc.

    Developing novel therapeutics to treat human respiratory diseases
  • Altea Therapeutics Corporation

    Altea Therapeutics Corporation

    Delivery of drugs across the skin
  • Amgen Inc.

    Amgen Inc.

    Focused on products for supportive cancer care, inflammation, nephrology and bone disease
    http://www.amgen.com
  • Amylin Pharmaceuticals, Inc.

    Amylin Pharmaceuticals, Inc.

    Development of drugs to treat metabolic diseases
    Acquired by Bristol-Myers Squibb
  • Ansata Therapeutics, Inc.

    Ansata Therapeutics, Inc.

    Drug development utilizing cell targeting technology
  • Antios Therapeutics, Inc.

    Antios Therapeutics, Inc.

    Late-stage pre-clinical company focused on the treatment of the Hepatitis B Virus
    http://antiostherapeutics.com
  • Apnex Medical, Inc.

    Apnex Medical, Inc.

    Developing a device-based treatment for obstructive sleep apnea
  • Applied Biosystems

    Applied Biosystems

    Technology solutions for DNA, RNA, protein, and small molecule analysis
    http://www.appliedbiosystems.com
    Acquired by Perkin Elmer; merged with Invitrogen to form Life Technologies
  • Applied Molecular Evolution, Inc.

    Applied Molecular Evolution, Inc.

    Gene evolution technology to optimize proteins for drug and industrial use
    Acquired by Eli Lilly & Co.
  • Applied Proteomics, Inc.

    Applied Proteomics, Inc.

    Developing protein biomarkers to improve healthcare and drug development
  • Ariosa Diagnostics, Inc.

    Ariosa Diagnostics, Inc.

    Focused on providing early, non-invasive, and accurate prenatal diagnostic tests for fetal health
    http://www.ariosadx.com
    Acquired by Roche
  • Ascenta Therapeutics, Inc.

    Ascenta Therapeutics, Inc.

    Anti-cancer drug development
  • Asmacure, Inc.

    Asmacure, Inc.

    Developing therapeutics for the treatment of asthma
    http://www.asmacure.com
    Acquired by Odan Laboratories, Inc.
  • Aspen Neuroscience, Inc.

    Aspen Neuroscience, Inc.

    Regenerative medicine company developing an autologous cell therapy for the treatment of Parkinson’s disease
    https://www.aspenneuroscience.com/
  • Astute Medical, Inc.

    Astute Medical, Inc.

    Developing innovative, high value, biomarker solutions for the acute hospital setting
    http://www.astutemedical.com
    Acquired by bioMerieux
  • Atara Biotherapeutics, Inc.

    Atara Biotherapeutics, Inc.

    Developing novel treatment options for patients with cancer and renal disease
    http://www.atarabio.com/
  • Athena Neurosciences, Inc.

    Athena Neurosciences, Inc.

    Development of diagnostics and therapeutics for Alzheimer's Disease
    Acquired by Elan Corporation
  • AtheroGenics, Inc.

    AtheroGenics, Inc.

    Discovery and development of drugs for inflammatory diseases
  • aTyr Pharma, Inc.

    aTyr Pharma, Inc.

    Developing Physiocrines, a novel class of naturally occuring biologics, for human therapeutics
    http://www.atyrpharma.com
  • Aurora Biosciences Corporation

    Aurora Biosciences Corporation

    Automation to facilitate drug discovery processes
    Acquired by Vertex Pharmaceuticals
  • Auxeris Therapeutics, Inc.

    Auxeris Therapeutics, Inc.

    Osteoporosis drug development
  • Axial Therapeutics, Inc.

    Axial Therapeutics, Inc.

    Developing a new class of therapeutics to improve the quality of life for patients with CNS diseases and disorders
    http://axialtx.com
  • Benvenue Medical, Inc.

    Benvenue Medical, Inc.

    Developing devices for the treatment of back pain
    http://www.benvenuemedical.com
  • Biomagnetic Technologies Inc.

    Biomagnetic Technologies Inc.

    Instrumentation for ultra-sensitive magnetic measurement
  • BioNano Genomics, Inc.

    BioNano Genomics, Inc.

    Developing technologies for analysis of large biological molecules
    http://www.bionanogenomics.com
  • Biosite Diagnostics, Inc.

    Biosite Diagnostics, Inc.

    Discovery, development and marketing of rapid diagnostics
    Acquired by Alere, Inc.
  • BioVascular, Inc.

    BioVascular, Inc.

    Developing solutions for reducing inflammation and thrombosis
    http://www.biovascularinc.com
  • BiPar Sciences, Inc.

    BiPar Sciences, Inc.

    Developing and commercializing potential new classes of tumor-selective drugs
    Acquired by sanofi-aventis
  • British Biotech

    British Biotech

    Diversified life-sciences company developing both drugs and research products
    Merged with Vernalis pls
  • Cabrellis Pharmaceuticals Corporation

    Cabrellis Pharmaceuticals Corporation

    Development of important therapies for the treatment of cancer
    Acquired by Pharmion Corporation; Acquired by Celgene
  • Cadence Pharmaceuticals, Inc.

    Cadence Pharmaceuticals, Inc.

    Development and marketing of acute care drugs with an initial focus on anti-infectives
    Acquired by Mallinckrodt
  • Cadent Medical Corporation

    Cadent Medical Corporation

    Life-saving external defibrillators
    Acquired by Cardiac Science, Inc.
  • Calixa Therapeutics, Inc.

    Calixa Therapeutics, Inc.

    Focused on developing, acquiring and commercializing hospital-based anti-infective therapies
    Acquired by Cubist Pharmaceuticals, Inc.
  • Cantex Pharmaceuticals, Inc.

    Cantex Pharmaceuticals, Inc.

    Developing a proprietary, modified form of heparin to treat a range of inflammatory diseases
    http://www.cantex.com
  • Cardiac Science Corporation

    Cardiac Science Corporation

    Life-saving external defibrillators
    http://www.cardiacscience.com
  • CardioDynamics International Corporation

    CardioDynamics International Corporation

    Noninvasive digital heart monitoring devices
    Acquired by SonoSite, Inc.
  • CardioPolymers, Inc.

    CardioPolymers, Inc.

    Novel therapies for diseases of cardiac conduction
    Merged with Lonestar Heart, Inc.
  • CareCentric Solutions, Inc.

    CareCentric Solutions, Inc.

    Information systems for the home care industry
    Acquired by Simione Central Holdings (renamed Care Centric); Acquired by Mediware
  • Carticept Medical, Inc.

    Carticept Medical, Inc.

    Development and sales of therapeutically related medical devices
    http://www.carticept.com
  • Cartiva, Inc.

    Cartiva, Inc.

    Development of medical devices to treat knee and small joint disease
    http://www.cartiva.net
  • Celator Pharmaceuticals, Inc.

    Celator Pharmaceuticals, Inc.

    Development of proprietary fixed dose combinations of chemotherapeutic agents for cancer treatment
    http://www.celatorpharma.com/
    Acquired by Jazz Pharmaceuticals
  • Celladon Corporation

    Celladon Corporation

    Developing treatments for cardiovascular diseases through molecular cardiology
  • Celtaxsys, Inc.

    Celtaxsys, Inc.

    Focused on treatments for inflammatory disease via regulation of immune cell migration & activation
  • Cerexa, Inc.

    Cerexa, Inc.

    Focused on developing, acquiring and commercializing hospital-based anti-infective therapies
    Acquired by Forest Laboratories, Inc.; Acquired by Actavis, now Allergan
  • ChromaCode, Inc.

    ChromaCode, Inc.

    Developing intelligent multiplexing for qPCR based diagnostic systems
    http://www.chromacode.com
  • Ciblex Corporation

    Ciblex Corporation

    Development of drugs that impact protein trafficking for use in proliferative disorders
  • Clovis Oncology, Inc.

    Clovis Oncology, Inc.

    Focused on acquiring, developing and commercializing innovative anti-cancer agents
    http://www.clovisoncology.com
  • CoCensys, Inc.

    CoCensys, Inc.

    Development of CNS drugs targeted at novel CNS receptors
    Acquired by Purdue Pharma
  • Colorescience, Inc.

    Colorescience, Inc.

    Markets products which fuse the beauty of traditional makeup with the benefits and efficacy of skin care and sun protection
    http://www.colorescience.com
  • CoLucid Pharmaceuticals, Inc.

    CoLucid Pharmaceuticals, Inc.

    Developing innovative therapies to treat CNS disorders
    http://www.colucid.com
  • Conforma Therapeutics Corporation

    Conforma Therapeutics Corporation

    Anti-cancer drug development
    Acquired by Biogen IDEC
  • Connetics Corporation

    Connetics Corporation

    Development and marketing of dermatology drugs
    Acquired by Stiefel Laboratories, Inc.
  • Corridor Pharmaceuticals, Inc.

    Corridor Pharmaceuticals, Inc.

    Developing therapeutics for vascular and pulmonary indications
  • Corthera, Inc.

    Corthera, Inc.

    Development of Relaxin for various indications
    Acquired by Novartis Pharmaceuticals Corporation
  • Cortria Corporation

    Cortria Corporation

    Developing safe and well-tolerated medicines to fight cardiovascular disease
    Acquired by Pharmena SA
  • Cotera, Inc.

    Cotera, Inc.

    Developing new and innovative orthopedic devices
  • Creative Biomolecules, Inc.

    Creative Biomolecules, Inc.

    Development of regenerative medicines
    Merged into Curis, Inc.
  • Cytovia, Inc.

    Cytovia, Inc.

    Drug screening technology using proprietary apoptosis assays
    Acquired by Maxim Pharmaceuticals, Inc.; Acquired by EpiCept Corporation
  • DIANON Sytems Inc.

    DIANON Sytems Inc.

    Provides anatomic and clinical pathology, patient information, and business solutions
    http://www.dianon.com
    Acquired by Laboratory Corporation of America
  • Dicerna Pharmaceuticals, Inc.

    Dicerna Pharmaceuticals, Inc.

    Developing RNA dicer substrates to treat a variety of diseases
    http://www.dicerna.com
  • DiObex, Inc.

    DiObex, Inc.

    Development of drugs to improve the management of diabetic patients
    http://www.diobex.com
  • DNX Corporation

    DNX Corporation

    Development of in vitro and in vivo biological models
    Merged with BioClin to form Chrysalis International Corporation, subsequently acquired by Phoenix International Life Sciences, part of MDS Pharma
  • Domain AntiBacterial Acquisition Corporation

    Domain AntiBacterial Acquisition Corporation

    In-licensing of anti-infective drugs
    Acquired by Peninsula Pharmaceuticals, Inc.; Acquired by Johnson & Johnson
  • Domain Elite Holdings Ltd.

    Domain Elite Holdings Ltd.

    A unique collaboration designed to create businesses in China
  • DRI Holdings Limited

    DRI Holdings Limited

    Formed in conjuction with Rusnano to provide funding for Domain companies and establish NovaMedica
    http://dri.ru.com
  • Dura Pharmaceuticals, Inc.

    Dura Pharmaceuticals, Inc.

    Specialty pharmaceutical company focused on respiratory drugs
    Acquired by Elan Corporation
  • Durata Therapeutics, Inc.

    Durata Therapeutics, Inc.

    Development of Dalbavancin, a glycopeptide anti-bacterial agent
    http://www.duratatherapeutics.com
    Acquired by Actavis plc.
  • Eddingpharm International Holdings Limited

    Eddingpharm International Holdings Limited

    Marketing oncology products in China
    http://www.eddingpharm.com
  • Embrex, Inc.

    Embrex, Inc.

    Unique delivery system for poultry vaccines and therapeutics
    Acquired by Pfizer Animal Health
  • Epic Sciences, Inc.

    Epic Sciences, Inc.

    Developing new diagnostics for management of cancer
    http://www.epicsciences.com
  • ESP Pharma, Inc.

    ESP Pharma, Inc.

    Acquires & markets acute care products
    Acquired by Protein Design Labs, Inc.
  • Esperion Therapeutics, Inc.

    Esperion Therapeutics, Inc.

    Developing pharmaceutical products for the treatment of cardiovascular and metabolic diseases
    http://www.esperion.com
  • Esprit Pharma, Inc.

    Esprit Pharma, Inc.

    Acquisition, development and marketing of drugs for the urology and OB-GYN physician communities
    Acquired by Allergan, Inc.
  • Eunoe, Inc.

    Eunoe, Inc.

    Device to treat Alzheimer's disease
  • Evofem Biosciences, Inc.

    Evofem Biosciences, Inc.

    Developing a portfolio of therapeutic solutions to meet the evolving sexual and reproductive health needs of women globally
    http://www.evofem.com
  • Evoke Pharma, Inc.

    Evoke Pharma, Inc.

    Acquisition and development of proprietary products for the treatment of gastrointestinal diseases
    http://www.evokepharma.com
  • Exalys Therapeutics, Inc.

    Exalys Therapeutics, Inc.

    Developing a family of EP4 Antagonists for the treatment of inflammatory disorders, including pain and renal dysfunction
    https://exalystx.com/
  • Exelixis, Inc.

    Exelixis, Inc.

    Genomics-based drug discovery
    http://www.exelixis.com
  • Five Prime Therapeutics, Inc.

    Five Prime Therapeutics, Inc.

    Expression and screening of all secreted proteins to find relevant protein therapeutics
    http://www.fiveprime.com
  • Focal, Inc.

    Focal, Inc.

    Biodegradable materials for the prevention of surgical adhesions
    Acquired by Genzyme BioSurgery
  • Fractyl Health, Inc.

    Fractyl Health, Inc.

    Developing device based treatment for chronic disease
    http://www.fractyl.com
  • Fusion Medical Technologies, Inc.

    Fusion Medical Technologies, Inc.

    Biomaterial for use in surgical procedures to prevent adhesions
    Acquired by Baxter Healthcare Corporation
  • GelTex Pharmaceuticals, Inc.

    GelTex Pharmaceuticals, Inc.

    Polymer technology for drugs that stay in the GI tract and remove toxins
    Acquired by Genzyme
  • Gene Sciences, Inc.

    Gene Sciences, Inc.

    Developing a new oncology product for treatment of late-stage prostate cancer
  • GeneOhm Sciences, Inc.

    GeneOhm Sciences, Inc.

    Molecular diagnostics
    Acquired by Becton, Dickinson and Company
  • GenQuest, Inc.

    GenQuest, Inc.

    Gene identification for diagnostic and therapeutic applications
    Acquired by Corixa Corporation; Acquired by GlaxoSmithKline
  • Gensia Pharmaceuticals Inc.

    Gensia Pharmaceuticals Inc.

    Development of drugs to treat cardiovascular diseases
    Merged into Sicor; Acquired by Teva Pharmaceuticals
  • Genta Incorporated

    Genta Incorporated

    Development of antisense therapeutics
  • GenVault Corporation

    GenVault Corporation

    High capacity DNA storage systems
    Acquired by IntegenX, Inc.
  • Geron Corporation

    Geron Corporation

    Discovery of mechanisms and therapeutics that impact the aging process
    http://www.geron.com
  • GI Dynamics, Inc.

    GI Dynamics, Inc.

    Device to treat obesity
    http://www.gidynamics.com
  • Glaukos Corporation

    Glaukos Corporation

    Device to treat glaucoma
    http://www.glaukos.com
  • GlycoDesign

    GlycoDesign

    Development of novel therapeutics for treatment of cancer, infectious diseases and inflammation
    Acquired by Inflazyme
  • Goodwell Technologies, Inc.

    Goodwell Technologies, Inc.

    IT to allow for remote doctor-patient interaction
    http://www.goodwelltech.com
  • Gynecare, Inc.

    Gynecare, Inc.

    Medical devices for women's healthcare
    Acquired by Johnson & Johnson
  • Helixis, Inc.

    Helixis, Inc.

    Developing a molecular diagnostic testing platform for use in diverse physical locations
    Acquired by Illumina, Inc.
  • Imagine Pharmaceuticals, Inc.

    Imagine Pharmaceuticals, Inc.

    Technology to facilitate delivery of drugs to the brain
  • Imagyn Medical, Inc.

    Imagyn Medical, Inc.

    Medical devices for gynecological indications
    Acquired by UroHealth, renamed Imagyn Medical Technologies, Inc.
  • Immune Control, Inc.

    Immune Control, Inc.

    Developing drugs to stop undesirable proliferation of immune cells
    Merged with Corridor Pharmaceuticals, Inc.
  • Immunex Corporation

    Immunex Corporation

    Focused on products for rheumatoid arthritis, acute nonlymphocytic leukemia and pain
    Acquired by Amgen
  • Inspire Pharmaceuticals, Inc.

    Inspire Pharmaceuticals, Inc.

    Drug development for ophthalmic and respiratory diseases
    Acquired by Merck & Co.
  • IntegenX Inc.

    IntegenX Inc.

    Developing equipment for molecular diagnostics
    http://www.integenx.com
    Acquired by Thermo Fisher Scientific, Inc.
  • IntraLase Corporation

    IntraLase Corporation

    Devices for laser correction of vision
    Acquired by Advanced Medical Optics, Inc., Acquired by Abbott Laboratories
  • Iomai Corporation

    Iomai Corporation

    Transdermal vaccines
    Acquired by Intercell AG
  • Ista Pharmaceuticals, Inc.

    Ista Pharmaceuticals, Inc.

    Drug development for ophthalmic diseases
    Acquired by Bausch & Lomb
  • Iterum Therapeutics Plc

    Iterum Therapeutics Plc

    Developing differentiated anti-infectives aimed at combating multi-drug resistant pathogens to treat serious and life-threatening diseases
    http://iterumtx.com
  • Kalidex Pharmaceuticals, Inc.

    Kalidex Pharmaceuticals, Inc.

    Providing next-generation anti-infective therapies to the marketplace
  • Kona Medical, Inc.

    Kona Medical, Inc.

    Developing methods to non-invasively inhibit or ablate nerves
    http://www.konamedical.com
  • Konova, Inc.

    Konova, Inc.

    Anti-obesity drug development
  • LaJolla Pharmaceutical Company

    LaJolla Pharmaceutical Company

    Development of therapeutics for antibody-related disorders
    http://www.ljpc.com
  • Landec Corporation

    Landec Corporation

    Crystallizable polymers for a variety of medical and industrial applications
    http://www.landec.com
  • Lumisys, Inc.

    Lumisys, Inc.

    High-performance electro-optical systems for medical imaging
    Acquired by Eastman Kodak
  • Marinus Pharmaceuticals, Inc.

    Marinus Pharmaceuticals, Inc.

    Development of therapeutics for treatment of CNS disorders and pain
    http://www.marinuspharma.com
  • Medico (Hong Kong) Limited

    Medico (Hong Kong) Limited

    Chinese affiliate of Smart Medical Systems Ltd. Developing and commercializing novel endoscopic products for the Chinese market
  • Meritage Pharma, Inc.

    Meritage Pharma, Inc.

    Developing drugs for gastrointestinal diseases
    Acquired by Shire plc
  • Microgon Inc.

    Microgon Inc.

    Hollow-fiber membrane filters for use in research laboratories
    Acquired by Spectrum Laboratories
  • Microsurge

    Microsurge

    Improved instrumentation for minimally invasive surgery
    Acquired by UroHealth, renamed Imagyn Medical Technologies, Inc.
  • MicroVention, Inc.

    MicroVention, Inc.

    Interventional neurology devices
    http://www.microvention.com
    Acquired by Terumo Corporation
  • MIGENIX Inc.

    MIGENIX Inc.

    Development of drugs for the prevention and treatment of infectious diseases
  • Milestone Pharmaceuticals, Inc.

    Milestone Pharmaceuticals, Inc.

    Developing fast-acting therapies to resolve cardiac rhythm disorders
    http://www.milestonepharma.com
  • Miramar Labs, Inc.

    Miramar Labs, Inc.

    Developing devices for aesthetic indications
    http://www.miramarlabs.com
    Acquired by Sientra, Inc.
  • MitoKor

    MitoKor

    Discovery and development of drugs for mitochondrial diseases
    Acquired by Micrologix Biotech Inc. (now MIGENIX Inc.)
  • Molecular Dynamics

    Molecular Dynamics

    Use of optical technology to automate laboratory processes
    Acquired by Amersham Pharmacia Biotech
  • Molecular Staging, Inc.

    Molecular Staging, Inc.

    Biomarker discovery utilizing novel DNA/RNA amplification technology
    Acquired by Qiagen
  • Nanothera Corporation

    Nanothera Corporation

    Developing safer parenteral products for hospital use
  • Neose Technologies, Inc.

    Neose Technologies, Inc.

    Enhancement of drugs by glcyosylation
    Assets sold to Novo Nordisk & BioGeneriX
  • Neuralieve, Inc.

    Neuralieve, Inc.

    Developing a non-invasive medical device to treat migraine headaches
  • NeuroPace, Inc.

    NeuroPace, Inc.

    Device to treat epilepsy
    http://www.neuropace.com
  • Nobias Therapeutics, Inc.

    Nobias Therapeutics, Inc.

    Discovering the genetic basis of rare pediatric diseases and developing drugs that can intervene in the affected pathways
  • Northstar Neuroscience, Inc.

    Northstar Neuroscience, Inc.

    Electrical stimulation to treat neurological defects
  • NovaCardia, Inc.

    NovaCardia, Inc.

    Cardiovascular drug development
    Acquired by Merck & Co., Inc.
  • Novacea, Inc.

    Novacea, Inc.

    Anti-cancer drug development
    Merged into Transcept Pharmaceuticals, Inc.
  • Novadigm Therapeutics, Inc.

    Novadigm Therapeutics, Inc.

    Developing vaccines and therapeutics to prevent and treat infectious diseases
    http://www.novadigm.net
  • Novalar Pharmaceuticals, Inc.

    Novalar Pharmaceuticals, Inc.

    Development of dental medications
  • NPS Pharmaceuticals, Inc.

    NPS Pharmaceuticals, Inc.

    Development of drugs for bone, GI, and CNS diseases
    Acquired by Shire plc
  • Nuon Therapeutics, Inc.

    Nuon Therapeutics, Inc.

    Developing medicines to treat autoimmune disease
  • NuVasive, Inc.

    NuVasive, Inc.

    Devices to assist in spinal surgery
    http://www.nuvasive.com
  • Obalon Therapeutics, Inc.

    Obalon Therapeutics, Inc.

    Developing an orally available intragastric balloon for the treatment of obesity
    http://www.obalon.com
  • Oceana Therapeutics, Inc.

    Oceana Therapeutics, Inc.

    Acquire and market drugs
    Acquired by Salix Pharmaceuticals, Inc.
  • Ocera Therapeutics, Inc.

    Ocera Therapeutics, Inc.

    Development of drugs to treat gastrointestinal diseases
    http://www.ocerainc.com
    Acquired by Mallinckrodt
  • Ocunexus Therapeutics, Inc.

    Ocunexus Therapeutics, Inc.

    Development and commercialization of proven gap junction channel modulation technologies targeting unmet clinical needs in ophthalmology
    https://www.ocunexus.com
  • Omniome, Inc.

    Omniome, Inc.

    Developing a novel approach to genomic analysis
    http://www.omniome.com
    Acquired by Pacific Biosciences, Inc.
  • OmniSonics Medical Technologies, Inc.

    OmniSonics Medical Technologies, Inc.

    Device to remove vascular occlusions
    http://www.omnisonics.com
  • OncoTherapeutics, Inc.

    OncoTherapeutics, Inc.

    Cancer diagnostics and therapeutics based on Kallikrein family of proteins
    Acquired by Biomira Inc., now Oncothyreon
  • Onux Medical, Inc.

    Onux Medical, Inc.

    Minimally invasive surgical tools
    Acquired by Davol, Inc., a subsidiary of C.R. Bard, Inc.
  • Onyx Pharmaceuticals, Inc.

    Onyx Pharmaceuticals, Inc.

    Anti-cancer drug development
    Acquired by Amgen
  • Optherion, Inc.

    Optherion, Inc.

    Developing therapeutics for diseases involving the complement system, with an initial focus on AMD
  • OraPharma, Inc.

    OraPharma, Inc.

    Development of dental medications
    http://www.orapharma.com
    Acquired by Johnson & Johnson
  • Oraya Therapeutics, Inc.

    Oraya Therapeutics, Inc.

    Developing a radiation-based treatment for wet AMD
  • Orexigen Therapeutics, Inc.

    Orexigen Therapeutics, Inc.

    Anti-obesity drug development
    http://www.orexigen.com
  • Origin Medsystems Inc.

    Origin Medsystems Inc.

    Instruments and devices for minimally invasive surgery
    Acquired by Eli Lilly/Guidant; Acquired by Boston Scientific
  • Orqis Medical Corporation

    Orqis Medical Corporation

    Device to treat congestive heart failure
  • Otonomy, Inc.

    Otonomy, Inc.

    Developing novel drug therapies for disorders of the inner and middle ear
    http://www.otonomy.com
  • Peninsula Pharmaceuticals, Inc.

    Peninsula Pharmaceuticals, Inc.

    Anti-infective drug development
    Acquired by Johnson & Johnson
  • Pharmion Corporation

    Pharmion Corporation

    Acquires and markets hematology products
    Acquired by Celgene Corporation
  • Pointshare Corporation

    Pointshare Corporation

    Community-based healthcare intra and extranet solutions
  • ProteinSimple

    ProteinSimple

    Lab instrumentation enabling analysis of cell signaling activity
    http://www.proteinsimple.com
    Acquired by Bio-Techne
  • Proxima Therapeutics, Inc.

    Proxima Therapeutics, Inc.

    Novel system to deliver radiation to treat cancer
    Acquired by Cytyc Corporation; Acquired by Hologic, Inc.
  • Receptor BioLogix, Inc.

    Receptor BioLogix, Inc.

    Developing a new class of protein therapeutics called Intron Fusion Proteins
  • Regado Biosciences, Inc.

    Regado Biosciences, Inc.

    Developing rapidly reversible anti-clotting medications
    Regado Biosciences acquired Tobira Therapeutics, renamed Tobira Therapeutics
  • Resound Corporation

    Resound Corporation

    Revolutionary technology for hearing aids
    Merged into GN ReSound
  • REVA Medical, Inc.

    REVA Medical, Inc.

    Resorbable stent technology
    http://www.teamreva.com
  • ReVision Optics, Inc.

    ReVision Optics, Inc.

    Developing new technologies, products and procedures aimed at the correction of presbyopia
    http://www.revisionoptics.com
  • RiboGene, Inc.

    RiboGene, Inc.

    Therapeutics based on control of protein translation
    Merged with Cypros to form Questcor
  • RightCare Solutions, Inc.

    RightCare Solutions, Inc.

    An evidence-based technology company specializing in discharge planning and readmission management
    http://www.rightcaresolutions.com
    Acquired by naviHealth, a Cardinal Health company
  • ROX Medical, Inc.

    ROX Medical, Inc.

    Device to treat chronic obstructive pulmonary disease
  • Ruxton Pharmaceuticals, Inc.

    Ruxton Pharmaceuticals, Inc.

    Proprietary assays to discover and develop drugs to treat ALS
  • Santarus, Inc.

    Santarus, Inc.

    GI drug development using novel formulations
    Acquired by Salix Pharmaceuticals; Acquired by Valeant Pharmaceuticals
  • Sebacia, Inc.

    Sebacia, Inc.

    Developing novel technology to address a large unmet need in dermatology
    http://www.sebacia.com
  • Selective Genetics, Inc.

    Selective Genetics, Inc.

    Site-specific gene therapies primarily for tissue repair
  • Senomyx, Inc.

    Senomyx, Inc.

    Discovery and development of flavor enhancing chemicals
    http://www.senomyx.com
  • SenoRx, Inc.

    SenoRx, Inc.

    Surgical tools for breast disease
    Acquired by C.R. Bard, Inc.
  • Sepracor, Inc.

    Sepracor, Inc.

    Separation technology applied to drug discovery
    Merged with Dainippon Sumitomo to form Sunovion
  • Sequel Pharmaceuticals, Inc.

    Sequel Pharmaceuticals, Inc.

    Cardiovascular drug development
  • Sequent Medical, Inc.

    Sequent Medical, Inc.

    Dedicated to the development of innovative devices to treat neurovascular disease conditions
    http://www.sequentmedical.com
    Acquired by Terumo
  • Sera Prognostics, Inc.

    Sera Prognostics, Inc.

    Developing diagnostic tests for early prediction of preterm birth and other pregnancy complications
    http://www.seraprognostics.com
  • Seraphina Therapeutics, Inc.

    Seraphina Therapeutics, Inc.

    Leveraging the evolution of longevity to treat comorbidities of aging.
    http://seraphinatherapeutics.com
  • Sievers Instruments, Inc.

    Sievers Instruments, Inc.

    Novel detectors for gas chromatography
    Acquired by Ionics; Acquired by GE Infrastructure
  • Singular Genomics, Inc.

    Singular Genomics, Inc.

    Next generation sequencing company delivering on solutions for the rapidly growing genomics market
    https://singulargenomics.com/
  • SkinMedica, Inc.

    SkinMedica, Inc.

    Acquires & markets dermatologic products
    http://www.skinmedica.com
    Acquired by Allergan, Inc.
  • Small Molecule Therapeutics, Inc.

    Small Molecule Therapeutics, Inc.

    Discovery of small molecule drugs based on proprietary screening technology
    Acquired by MorphoChem AG
  • Smart Medical Systems Ltd.

    Smart Medical Systems Ltd.

    Developing and commercializing novel products to enable better endoscopy for the gastroenterologist
    http://www.smartmedsys.com
  • Somaxon Pharmaceuticals, Inc.

    Somaxon Pharmaceuticals, Inc.

    Development of psychiatric drugs
    Acquired by Pernix Therapeutics Holdings, Inc.
  • Sonexa Therapeutics, Inc.

    Sonexa Therapeutics, Inc.

    Developing therapeutics for the treatment of Alzheimer's disease
  • Syndax Pharmaceuticals, Inc.

    Syndax Pharmaceuticals, Inc.

    Development and commercialization of novel cancer therapies
    http://www.syndax.com
  • Tandem Diabetes Care, Inc.

    Tandem Diabetes Care, Inc.

    Developing novel devices for the treatment of diabetes
    http://www.tandemdiabetes.com
  • TargetRx, Inc.

    TargetRx, Inc.

    Information services for the pharmaceutical industry
    Acquired by ImpactRx, Inc.
  • Tobira Therapeutics, Inc.

    Tobira Therapeutics, Inc.

    Dedicated to the clinical development of antiviral products
    http://www.tobiratx.com
    Acquired by Allergan
  • Transposon Therapeutics, Inc.

    Transposon Therapeutics, Inc.

    Developing therapeutics for debilitating and life-threatening diseases
  • Trega Biosciences, Inc.

    Trega Biosciences, Inc.

    Combinatorial chemistry technology used to discover novel therapeutics
    Acquired by LION bioscience
  • Trimeris, Inc.

    Trimeris, Inc.

    Novel HIV therapeutics
    Merged with Synageva
  • Truvian Sciences, Inc.

    Truvian Sciences, Inc.

    Developing an automated benchtop system to make routine health testing convenient, affordable and actionable for consumers
    http://truvianhealth.com
  • Twelve, Inc.

    Twelve, Inc.

    An incubator focused on developing the next generation of medical device innovations
    Acquired by Medtronic
  • Univax Biologics

    Univax Biologics

    Vaccines to stimulate the plasma donor production of immunoglobulins
    Acquired by Nabi Pharmaceuticals; Merged with Biota Pharmaceuticals, Inc.
  • US Bioscience, Inc.

    US Bioscience, Inc.

    Acquisition and marketing of cancer drugs
    Acquired by MedImmune; Acquired by AstraZeneca
  • Valley Forge Pharmaceuticals, Inc.

    Valley Forge Pharmaceuticals, Inc.

    Anti-myopia drug development
  • Vanda Pharmaceuticals, Inc.

    Vanda Pharmaceuticals, Inc.

    Analysis of genetic, genomic and clinical date to rescue "failed" drugs
    http://www.vandapharma.com
  • Vascular Architects, Inc.

    Vascular Architects, Inc.

    Novel stent technology
    Acquired by LeMaitre Vascular
  • Vascular Therapeutics, Inc.

    Vascular Therapeutics, Inc.

    Biopharmaceuticals for the prevention and treatment of vascular disease
    Acquired by GlycoDesign; Acquired by Inflazyme
  • VenPro Corporation

    VenPro Corporation

    Intravascular valve technology
    Acquired by 3F Therapeutics; Acquired by ATS Medical; Acquired by Medtronic
  • VentiRx Pharmaceuticals, Inc.

    VentiRx Pharmaceuticals, Inc.

    Developing novel drugs for the treatment of cancer, infectious, respiratory and autoimmune diseases.
    http://www.ventirx.com
    Acquired by Celgene
  • Veracyte, Inc.

    Veracyte, Inc.

    Developing a molecular-based thyroid cancer diagnostic that permits diagnoses without surgery
    http://www.veracyte.com
  • Verus Pharmaceuticals, Inc.

    Verus Pharmaceuticals, Inc.

    Development and marketing of pediatric focused therapeutics
  • Viagene Inc.

    Viagene Inc.

    Gene manipulation technology for the discovery of anti-infective therapies
    Acquired by Chiron; Acquired by Novartis
  • Vista Medical Technologies, Inc.

    Vista Medical Technologies, Inc.

    Visualization technology to aid in surgical procedures
  • Vivus, Inc.

    Vivus, Inc.

    Therapeutics to treat sexual dysfunction
    http://www.vivus.com
  • Volcano Corporation

    Volcano Corporation

    Detection and treatment of vascular disease
    http://www.volcanocorp.com
    Acquired by Royal Philips
  • WindMIL Therapeutics, Inc.

    WindMIL Therapeutics, Inc.

    Novel cell therapy utilizing re-activated T-cells that normally lie dormant in cancer patients
    http://windmiltx.com
  • X-Ceptor Therapeutics, Inc.

    X-Ceptor Therapeutics, Inc.

    Drug development focused on orphan nuclear receptors
    Acquired by Exelixis, Inc.
  • Xagenic, Inc.

    Xagenic, Inc.

    Developing a true point-of-care platform to enable on-demand, near patient molecular testing
    http://www.xagenic.com
  • Xcel Pharmaceuticals, Inc.

    Xcel Pharmaceuticals, Inc.

    Acquires & markets neurology products
    Acquired by Valeant Pharmaceuticals International
  • Zogenix, Inc.

    Zogenix, Inc.

    Development and commercialization of medicines to treat CNS disorders and pain
    http://www.zogenix.com
  • Zyga Technology, Inc.

    Zyga Technology, Inc.

    Developing therapies for the treatment of back pain
    http://www.zyga.com
    Acquired by RTI Surgical, Inc.

Filter By:

Clear All Filters

  • SECTOR
  • PRIVATE/PUBLIC
  • IPO/M&A
  • FUND
  • REPRESENTATIVE
Privacy Policy | Site Map    
Domain on Twitter
Domain on LinkedIn
Domain Associates, LLC is a member of the National Venture Capital Association.
© 2023 Domain Associates, LLC. All rights reserved.
Domain Associates® is a registered trademark of Domain Associates, LLC.